Aspirin resistance

被引:4
作者
Michelson, Alan D.
机构
[1] Univ Massachusetts, Sch Med, Ctr Platelet Funct Studies, Dept Pediat, Worcester, MA 01655 USA
[2] Univ Massachusetts, Sch Med, Ctr Platelet Funct Studies, Dept Med, Worcester, MA 01655 USA
[3] Univ Massachusetts, Sch Med, Ctr Platelet Funct Studies, Dept Pathol, Worcester, MA 01655 USA
关键词
aspirin; drug resistance; aspirin resistance; platelets; coronary artery disease; stroke; thrombosis;
D O I
10.1159/000093570
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:5 / 9
页数:5
相关论文
共 33 条
[1]   Defective platelet response to arachidonic acid and thromboxane A2 in subjects with PlA2 polymorphism of β3 subunit (glycoprotein IIIa) [J].
Andrioli, G ;
Minuz, P ;
Solero, P ;
Pincelli, S ;
Ortolani, R ;
Lussignoli, S ;
Bellavite, P .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (04) :911-918
[2]  
Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
[3]   Aspirin resistance: More than just a laboratory curiosity [J].
Bhatt, DL .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (06) :1127-1129
[4]   Aspirin and clopidogrel - Efficacy, safety, and the issue of drug resistance [J].
Cattaneo, M .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (11) :1980-1987
[5]   Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment [J].
Chen, WH ;
Lee, PY ;
Ng, W ;
Tse, HF ;
Lau, CP .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (06) :1122-1126
[6]   Lack of aspirin effect: Aspirin resistance or resistance to taking aspirin? [J].
Cotter, G ;
Shemesh, E ;
Zehavi, M ;
Dinur, I ;
Rudnick, A ;
Milo, O ;
Vered, Z ;
Krakover, R ;
Kaluski, E ;
Kornberg, A .
AMERICAN HEART JOURNAL, 2004, 147 (02) :293-300
[7]   Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events [J].
Eikelboom, JW ;
Hirsh, J ;
Weitz, JI ;
Johnston, M ;
Yi, Q ;
Yusuf, S .
CIRCULATION, 2002, 105 (14) :1650-1655
[8]  
FRELINGER AL, 2005, J THROMB HAEMOST S1, V3
[9]   Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease. [J].
Gaspoz, J ;
Coxson, PG ;
Goldman, PA ;
Williams, LW ;
Kuntz, KM ;
Hunink, MGM ;
Goldman, L .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (23) :1800-1806
[10]   2-YEAR FOLLOW-UP OF ASPIRIN RESPONDER AND ASPIRIN NONRESPONDER - A PILOT-STUDY INCLUDING 180 POSTSTROKE PATIENTS [J].
GROTEMEYER, KH ;
SCHARAFINSKI, HW ;
HUSSTEDT, IW .
THROMBOSIS RESEARCH, 1993, 71 (05) :397-403